Literature DB >> 22426468

A new bioinformatics insight into human cancer-associated proteins.

Fu-Jun Liu1, Xiu-Feng Hua, Wen-Juan Wang.   

Abstract

Cancer is a complex disease caused by multiple factors including genetic mutations, and environmental factors. Cancer-associated proteins are potential biomarkers or targets for diagnostic and therapeutic interventions in cancer. The Universal Protein Resourse (UniPort) is a well-annotated comprehensive resourse for protein sequence records. In the present study, we performed data mining of Uniprot proteins as a proteomic resource. we generated a catalog of 1653 cancer-associated proteins including 344 secretory proteins and 300 cell surface proteins. Integrated bioinformatic analysis including ontological classification, functional enrichment and pathway construction were performed. These proteins could serve as a reference for further studies to discover cancer targets, and the enriched bioinformatic analysis provides new insights into cancer proteomics research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426468     DOI: 10.3892/or.2012.1714

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Functional analysis of human cancer-associated genes and their association with the testes and epididymis.

Authors:  Xiu-Feng Hua; Xue-Bo Wang; Fu-Jun Liu
Journal:  Oncol Lett       Date:  2013-07-08       Impact factor: 2.967

2.  Pancreatic insulin-producing cells differentiated from human embryonic stem cells correct hyperglycemia in SCID/NOD mice, an animal model of diabetes.

Authors:  Xiu-feng Hua; Yan-wei Wang; Yu-xiao Tang; Sheng-qiang Yu; Shao-hua Jin; Xiao-mei Meng; Hua-feng Li; Fu-jun Liu; Qiang Sun; Hai-yan Wang; Jian-yuan Li
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

3.  Screening and functional analysis of a differential protein profile of human breast cancer.

Authors:  Fu-Jun Liu; Xue-Bo Wang; Ai-Guo Cao
Journal:  Oncol Lett       Date:  2014-03-18       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.